Skip to main content

Table 2 Experimental design of 212 included studies

From: Temozolomide sensitivity of malignant glioma cell lines – a systematic review assessing consistencies between in vitro studies

Characteristics

N = 212

Base medium

 DMEM

141 (66.5%)

 Customised media

23 (10.8%)

 Eagle minimal essential medium

18 (8.5%)

 DMEM/F12

11 (5.2%)

 Neurobasal

2 (0.9%)

 Unspecified

17 (8.0%)

Serum supplementation

 Yes

190 (89.6%)

 No

1 (0.4%)

 Unknown

21 (9.9%)

Carbon dioxide (%)

 5

156 (73.6%)

 6

1 (0.5%)

 10

1 (0.5%)

 Unknown

54 (25.5%)

Temperature

 37°C

160 (75.5%)

 Unknown

52 (24.5%)

Hypoxic condition

 Used

5 (2.4%)

 Unknown

54 (25.5%)

Other methodological reporting

 Cell density

154 (72.6%)

 Number of cell passage

16 (7.5%)

 Number of replicates

58 (27.4%)

 Number of plate replicates

42 (19.8%)

  1. DMEM Dulbecco’s Modified Eagle Medium, DMEM/F12 Dulbecco's Modified Eagle Medium/Nutrient Mixture F-12